CURRICULUM VITAE INFORMAZIONI PERSONALI. Mosca Marta Data di nascita 11/09/1968. Numero telefonico dell ufficio. Fax dell ufficio

Transcript

1 INFORMAZIONI PERSONALI Nome Mosca Marta Data di nascita 11/09/1968 Qualifica Amministrazione Incarico attuale Numero telefonico dell ufficio dirigente medico UNIVERSITA' DEGLI STUDI DI PISA Incarico di studio - Reumatologia Fax dell ufficio istituzionale marta.mosca@int.med.unipi.it TITOLI DI STUDIO E PROFESSIONALI ED ESPERIENZE LAVORATIVE Titolo di studio Altri titoli di studio e professionali Esperienze professionali (incarichi ricoperti) Capacità linguistiche Capacità nell uso delle tecnologie Altro (partecipazione a convegni e seminari, pubblicazioni, collaborazione a riviste, ecc., ed ogni altra informazione che il dirigente ritiene di dover pubblicare) Laurea in Medicina e Chirurgia - Specializzazione in Allergologia e Immunologia Clinica Specializzazione in Reumatologia Dottorato di ricerca in Chirurgia, Biotecnologie e Immunologia dei trapianti - Specializzando in Immunologia clinica Dottorato di ricerca - UNIVERSITA' DEGLI STUDI DI PISA Lingua Livello Parlato Livello Scritto Inglese Eccellente Eccellente Francese Fluente Fluente Spagnolo Scolastico Scolastico - Esperienza in laboratorio nella esecuzione di colture cellulari esperienza in laboratorio nella esecuzione di PCR - Partecipazione in qualità di relatore a convegni della Società Italiana di Reumatologia negli anni 1999, 2003, 2005, 2006, 2007, 2008, 2009 Partecipazione in qualità di relatore ai convegni della Società Europea di Reumatologia negli anni 2007, 2008, 2009 Partecipazione a numerosi convegni italiani e straneir in qualità di relatore Autore di oltre 60 pubblicazioni su riviste internazionali, delle quali le più significative sono riportate di seguito M. Mosca et al. Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus. Lupus 1997; 6; M. Mosca, et al. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least one year. Lupus, 1998; 2: M. Mosca, et al. 1

2 Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol. 1999; 17 (5): IP M. Curcio, M. Mosca, et al. Usefulness of direct sequencing in the detection of microchimerism in liver transplant recipients. Transplantation 2000; 69: M. Mosca, et al. The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 2000; 9: M. Mosca, et al. Treatment of the idiopathic inflammatory myopathies: A retrospective analysis of 63 Caucasian patients longitudinally followed at a single center. Clinical Experimental Rheumatology 2000; 18, M. Mosca, et al. Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis. Lupus, 2001; 10: M. Mosca, et al. Treatment of systemic lupus erythematosus. Int Immunopharmacol 2001; 1: M Mosca, et al. Undifferentiated connective tissue diseases: a new frontier in rheumatology. Curr Rheumatol Rep. 2001; 3: S Crotta, A Stilla, A Waak, A D'Andrea, S Nuti, U D'Oro, M Mosca, et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med. 2002;195: M Mosca, et al. Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. Kidney Int. 2002; 61: M Mosca,et al. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum follow up of 5 years. J Rheumatol. 2002; 29: IP M Mosca, et al. Pregnancy outcome in patients with undifferentiated connective tissue disease: a preliminary study on 25 pregnancies. Lupus. 2002; 11: M. Mosca, et al. Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis. 2003; 62 (7): M Mosca, et al. Undifferentiated connective tissue diseases in the Clin Exp Rheumatol 2004; 22: S Mosca M, Baldini C, Bombardieri S. The value of outcome measures in autoimmune rheumatic diseases. Autoimmun Rev. 2004; 3: S Mosca M, et al. Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum. 2005; 53: Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol; 19. Mosca M, et al. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-c1q, and anti-dsdna antibodies in patients with systemic lupuserythematosus. J Rheumatol. 2006; 33: Tani C, Mosca M, et al. Chronic inflammation and 2

3 endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD. Reumatismo. 2006; 58: Mosca M, Bombardieri S. Assessing remission in systemic lupus erythematosus. Clin Exp Rheumatol. 2006; 24 (Suppl 43):S Mosca M, et al. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev. 2006; 6: Moroni G, Doria A, Mosca M, et al. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin J Am Soc Nephrol. 2006; 1: Mosca M, et al. Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus. Clin Exp Rheumatol May-Jun;25(3): Mosca M, et al. LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus. Expert Opin Pharmacother Apr;8(6): Mosca M, Bombardieri S. Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE). Clin Exp Rheumatol. 2007; 6 Suppl 47: Mosca M, et al. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Practice & Research Clinical Rheumatology 2007; 21(6): Mosca M, et al. Anti-C1q antibodies in pregnant patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2007;25: Mosca M, et al. A case of undifferentiated connective tissue disease: is it a distinct clinical entity? Nature Clinical Practice Rheumatology 2008;4; Mosca M, et al. Defining undifferentiated connective tissue diseases: a challenge for rheumatologists. Lupus 2008;17: Rossi M, Mosca M, et al. Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus. Clin Rheumatol. 2008;27: Mosca M, et al. Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews. Clin Rheumatol Aug;27(8): Tani C, et al. Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases. Clin Exp Rheumatol 2009 ;27: Mosca M, et al Comparison of real-time PCR and nested PCR for the detection of Y chromosome sequences in the peripheral blood mononuclear cells of patients with systemic sclerosis. Ann Rheum Dis 2009 ;6: Ghiadoni L, Mosca M, et al. Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases. Clin Exp Rheumatol Jul-Aug;26(4): Mosca M, et al. Vascular reactivity in patients with undifferentiated connective tissue diseases. Atherosclerosis. 2009;203(1): Antonelli A, Mosca M, et al. Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study. J Clin 3

4 Endocrinol Metab Nov 11. [Epub ahead of print] 38. Mosca M, et al. EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Ann Rheum Dis Nov Mosca M,et al Cell-free DNA in the plasma of patients with systemic sclerosis. Clin Rheumatol Dec;28(12):

5 RETRIBUZIONE ANNUA LORDA RISULTANTE DAL CONTRATTO INDIVIDUALE Amministrazione: UNIVERSITA' DEGLI STUDI DI PISA dirigente: Mosca Marta incarico ricoperto: Incarico di studio - Reumatologia stipendio tabellare posizione parte fissa posizione parte variabile retribuzione di risultato altro* TOTALE ANNUO LORDO 0,00 0,00 0,00 0,00 0,00 0,00 *ogni altro emolumento retributivo non ricompreso nelle voci precedenti 5